OPHLY Ono Pharmaceutical (ADR)
- 4.940
- +0.030+0.61%
- 4.920
- -0.020-0.40%
Ono Pharmaceutical (ADR) News
Deciphera Pharmaceuticals: A Hold Rating Amidst Ono Pharmaceutical Acquisition Offer
Ono Pharmaceutical: Extraordinary Report
Earnings Call Summary | ONO PHARMACEUTICAL CO(OPHLF.US) Q1 2024 Earnings Conference
The following is a summary of the Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript:Financial Performance:Ono Pharmaceutical reported Q1 revenue of ¥502.7 billion, marking their fi
Fuji HD, Rinnai, etc. (added) Rating
Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|------------|------------|------------|---------|＜9229＞|SunWells |Nomura | “Neutral” | “Buy” |＜9434＞|SoftBank | Germany | “Hold” | “Buy” |Target Stock Price Change Code
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1663＞ K&O Energy 3295 3515 ＜1870＞ Yahagi Ken 1501 1570 ＜1930＞ Hokuriku Denko 1146 1201 ＜1968＞ Taiheiden 4295 4480 ＜2579＞ Coca BJH
3 points worth paying attention to in the backfield ~ a solid development with over 70% rising
I would like to pay attention to the following 3 points in the late-day transaction on the 9th.
It is a solid development with a rise of over 70%
[Nikkei Stock Average, TOPIX (table)] Nikkei Average; 38392.10; +189.73 TOPIX; 2727.05; +20.62 [Backstage Investment Strategy] The aftermarket draws attention to financial results announced during trading hours. At 12:00, Asahi Kasei ＜3407＞, Ono Yaku＜4528＞, Sumitomo Riko ＜5191＞, Chiyoken ＜6366＞, SMK ＜6798＞, and at 13:00, Sumidensetsu ＜1949＞, Daicel ＜4202＞, Pia ＜4337＞, Hokuetsu Engineering ＜6364＞, Takashima ＜8
The Nikkei Average rebounded, and there was a steady development where it rose by over 70%
The Nikkei Average rebounded. The front-end transaction was closed at 38392.10 yen (estimated turnover of 840 million shares), which was 189.73 yen higher (+0.50%) compared to the previous day. The US stock market on the 8th was mixed. The Dow average closed at 39056.39 dollars (+ 0.44%), the Nasdaq was 29.80 points lower (-0.18%) at 16302.76, and the S&P 500 was 0.03 points lower (-0.00%) at 5187.67. Selling to postpone interest rate cuts
Express News | Ono Pharm 2023/24 Group (Ifrs) Pretax Profit 163.73 Bln Yen (+14.1 %), 2024/25 Forecast Profit 123.00 Bln Yen (-24.9 %)
Express News | Ono Pharm 2023/24 Group (Ifrs) Operating Profit 159.94 Bln Yen (+12.7 %), 2024/25 Forecast Profit 122.00 Bln Yen (-23.7 %)
Express News | Ono Pharm 2023/24 Group (Ifrs) Net Profit 127.98 Bln Yen (+13.5 %) , 2024/25 Forecast Profit 91.00 Bln Yen (-28.9 %)
Ono Pharmaceutical FY Net Y127.98B Vs Net Y112.72B
Ono Pharmaceutical Co. Ltd. (4528.TO) Osaka Year Ended March 31 GROUP 2024 2023 Revenue Y502.67 bln Y447.19 bln Operating Profit Y159.94 b
Ono Pharmaceutical Sees FY Net Y91.00B
Ono Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Mar 2025 Revenue Y450.00 bln Operating Profit Y122.00 bln Preta
Ono Pharmaceutical: Financial Results for the Fiscal Year Ending March 31, 2024 [IFRS] (Consolidated)
Ono Pharmaceutical: Supplemental Financial Results for the Fiscal Year Ending March 31, 2012 (Consolidated IFRS)
Ono Pharmaceutical: Notice regarding differences between individual results and previous fiscal year results
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) ＜1375＞Snow Country Maitake ＜1720＞Tokyu Construction＜1738＞Nittoh ＜1764＞Kudo Construction＜1788＞Santo Kogyo ＜1799＞Daiichi Kenset＜1869＞Meikouken ＜1870＞Yahagi Kenset＜1929
Convertible Stock List (Part 5) [Parabolic Signal Convertible Stock List]
○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1944＞ Kinden 3013 3215 ＜1959＞ Kyudenko 6552 7139 ＜1969＞ Takasago fever 5290 5600 ＜2503＞ Kirin HD 2301 ＜3608＞ TSI HD 880 926 ＜4021＞ Nissanka
3 points you should pay attention to in the front field ~ centered on searching using financial results as clues ~
I would like to pay attention to the following 3 points in the transaction before 5/1. ■ Searching using financial results as clues ■ Japan Post, 24/3 upward revision ordinary profit 660 billion yen ← 62 billion yen ■ front-end notable materials: Nissan's own, low-cost inverter development, equipped with general-purpose semiconductors ■ The one-day Japanese stock market is centered around searching with financial results, and after starting ahead of sales, it seems that the market is likely to develop where a sense of stalemate tends to gradually intensify. In the US market on April 30, the NY Dow depreciated by $570 and NASDAQ
Nissan, Ono Yakuji, etc. [List of brand materials from newspapers]
*Nissan's own ＜7201＞ low-cost inverter development, equipped with general-purpose semiconductors (Nikkan Kogyo 1 side) - ○*Ono Yaku＜4528＞ acquires rice companies for 370 billion yen, cancer area development enhancement (Nikkan Kogyo 3 sides) - ○*Tohoku Electric Power ＜9506＞ strategic investment of 300 billion yen, business development/finance/management policy (Nikkan Kogyo 3 sides) - ○*BIPGY ＜8056＞ new mid-term budget, growth investment 70 billion yen, M&A acceleration (Nikkan Kogyo 3 sides) -○*Hitachi Shipbuilding ＜7004＞Biogas Plant in Europe Accelerated development (Nikkan Kogyo 4)
Analysis
Price Target
No Data
